Examples that have already been reported include a mutation in a RET enhancer that increases Hirschsprung disease risk [87,88] as well as mutations that affect thalassemia, hemophilia, hypercholesterolemia, and pyruvate kinase deficiency [89]. The gene discussed is RET; the disease is Hemolytic anemia due to red cell pyruvate kinase deficiency.